ctDNA-based minimal residual disease detection in lung cancer patients treated with curative intended chemoradiotherapy using a clinically transferable approach

Background: Reliable biomarkers are needed to identify tumor recurrence of non-small cell lung cancer (NSCLC) patients after chemoradiotherapy (CRT) with curative intent. This could improve consolidation therapy of progressing patients. However, the approach of existing studies has limited transfera...

Full description

Bibliographic Details

Published in:	Cancer Treatment and Research Communications
Main Authors:	Lærke Rosenlund Nielsen, Simone Stensgaard, Peter Meldgaard, Boe Sandahl Sorensen
Format:	Article
Language:	English
Published:	Elsevier 2024-01-01
Subjects:	NGS Biomarkers Liquid biopsies Time point Non-small cell lung cancer
Online Access:	http://www.sciencedirect.com/science/article/pii/S2468294224000145